Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

Jones, L; Griffin, S; Palmer, S; Main, C; Orton, V; Sculpher, M; Sudlow, C; Henderson, R; Hawkins, N; Riemsma, R

Jones, L; Griffin, S; Palmer, S; Main, C; Orton, V; Sculpher, M; Sudlow, C; Henderson, R; Hawkins, N; Riemsma, R.

Affiliation

Jones L; Centre for Reviews and Dissemination, University of York, UK.

Health Technol Assess ; 8(38): iii-iv, 1-196, 2004 Oct.

Article de En | MEDLINE | ID: mdl-15461876

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies vasculaires / Ticlopidine / Ischémie Type d'étude: Clinical_trials / Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Systematic_reviews Aspects: Patient_preference Langue: En Journal: Health Technol Assess Sujet du journal: PESQUISA EM SERVICOS DE SAUDE / TECNOLOGIA MEDICA Année: 2004 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Royaume-Uni

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links